Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:31:05 EST Sat 08 Nov 2025
Enter Symbol
or Name
USA
CA



News for U:ICU from 2024-11-08 to 2025-11-07 - 42 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2025-11-05 10:03U:ICUNews ReleaseSeaStar Medical to Report Third Quarter Financial Results on November 13, 2025
2025-09-29 08:36U:ICUNews ReleaseSeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children
2025-09-24 16:22U:ICUNews ReleaseSeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
2025-09-23 08:23U:ICUNews ReleaseSeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children
2025-09-04 18:14U:ICUNews ReleaseSeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference
2025-09-02 08:22U:ICUNews ReleaseSeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival
2025-08-13 16:05U:ICUNews ReleaseSeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates
2025-08-07 10:00U:ICUNews ReleaseSeaStar Medical to Report Second Quarter Financial Results on August 13, 2025
2025-08-06 08:33U:ICUNews ReleaseSeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)
2025-07-31 15:01U:ICUNews ReleaseSeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2025-07-22 08:20U:ICUNews ReleaseSeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients
2025-07-16 08:45U:ICUNews ReleaseSeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry
2025-07-10 15:30U:ICUNews ReleaseSeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2025-07-08 08:05U:ICUNews ReleaseSeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)
2025-07-02 16:25U:ICUNews ReleaseSeaStar Medical Announces Positive Nasdaq Listing Determination
2025-06-25 08:05U:ICUNews ReleaseSeaStar Medical Reports Update on Nasdaq Listing Status
2025-06-24 09:05U:ICUNews ReleaseSeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy
2025-06-20 12:10U:ICUNews ReleaseSeaStar Medical Announces Pricing of Up to $8 Million Public Offering
2025-06-11 08:25U:ICUNews ReleaseAREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research
2025-05-28 08:06U:ICUNews ReleaseSeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy
2025-05-14 16:05U:ICUNews ReleaseSeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates
2025-05-13 08:05U:ICUNews ReleaseSeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury
2025-05-07 10:00U:ICUNews ReleaseSeaStar Medical to Report First Quarter Financial Results on May 14, 2025
2025-04-30 08:05U:ICUNews ReleaseSeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time
2025-04-08 08:05U:ICUNews ReleaseFDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery
2025-03-27 16:05U:ICUNews ReleaseSeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
2025-03-24 17:30U:ICUNews ReleaseSeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025
2025-03-18 08:45U:ICUNews ReleaseNKF Honors SeaStar Medical, with 2025 Corporate Innovator Award
2025-02-03 16:05U:ICUNews ReleaseSeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market
2025-01-31 08:00U:ICUNews ReleaseSeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market
2025-01-27 08:00U:ICUNews ReleaseSeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE
2025-01-22 07:30U:ICUNews ReleaseSeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial
2025-01-13 08:30U:ICUNews ReleaseFDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
2025-01-08 08:30U:ICUNews ReleaseSeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer
2024-12-23 07:00U:ICUNews ReleaseSeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial
2024-12-11 06:30U:ICUNews ReleaseSeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
2024-12-04 08:30U:ICUNews ReleaseSeaStar Medical to Hold Business Update Conference Call on December 11, 2024
2024-12-03 08:30U:ICUNews ReleaseSeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial
2024-11-26 08:00U:ICUNews ReleaseSeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024
2024-11-22 08:30U:ICUNews ReleaseLeading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares
2024-11-15 08:30U:ICUNews ReleaseSeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer
2024-11-13 17:05U:ICUNews ReleaseSeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update